Inhibition of influenza virus A/WSN replication by a trypsin inhibitor, 6-amidino-2-naphthyl p-guanidinobenzoate.
A trypsin inhibitor, 6-amidino-2-naphthyl p-guanidinobenzoate (FUTHAN) reduced both the number and size of plaques of influenza virus A/WSN/33 (H1N1) that can grow without trypsin treatment in MDCK cells. The resulting virus particles with uncleaved hemagglutinin (HA) in the presence of FUTHAN was activated to produce infectious virions by trypsin treatment. Uncleaved HA of WSN virus grown in the presence of FUTHAN was found to be accumulated by protein analysis of WSN virus labeled biosynthetically with [35S]-methionine. It was strongly suggested that FUTHAN inhibited viral replication by preventing proteolytic cleavage of HA.
Someya
A
A
Exploratory Research Laboratories, Banyu Pharmaceutical Co., Ltd., Tokyo, Japan.
Tanaka
N
N
Okuyama
A
A
D001550:Benzamidines; D006146:Guanidines / Q000494:pharmacology*; D006389:Hemagglutinins, Viral / Q000378:metabolism; D009980:Influenza A virus / Q000187:drug effects / Q000502:physiology*; D014357:Trypsin / Q000494:pharmacology; D014361:Trypsin Inhibitors / Q000494:pharmacology*; D010948:Viral Plaque Assay; D014779:Virus Replication / Q000187:drug effects*
D001550:Benzamidines; D006146:Guanidines; D006389:Hemagglutinins, Viral; D014361:Trypsin Inhibitors; D014357:Trypsin; C032855:nafamostat